GRIFOLS | GRF - Selling And Administration Expenses

Stock Price
10.93
Daily Change
-0.03 -0.23%
Monthly
-3.27%
Yearly
34.61%
Q1 Forecast
10.50

GRIFOLS reported EUR284.99M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
Alcon AG USD 865M 5M Sep/2025
Amadeus IT EUR 497.5M 206.6M Mar/2025
Amarin USD 17.94M 17.86M Sep/2025
argenx SE USD 336.29M 14.94M Sep/2025
AstraZeneca USD 148M 4.86B Sep/2025
Bayer EUR 3.4B 140M Sep/2025
Cie Automotive EUR 315.66M 28.06M Dec/2024
Demant DKK 6.09B 135M Dec/2025
Ence Energia y Celulosa EUR 29.1M 2M Sep/2024
Essilor EUR 1.09B 2.08B Jun/2025
Ferrovial EUR 906M 52M Dec/2024
Fresenius EUR 676M 64M Sep/2025
Fresenius Medical Care EUR 705.44M 86.56M Sep/2025
Galapagos EUR 34.55M 3.88M Sep/2025
Genmab DKK 144M 18M Jun/2025
GlaxoSmithKline GBP 2.16B 19M Sep/2025
GRIFOLS EUR 284.99M 2.24M Sep/2025
Hikma Pharmaceutical USD 139M 149M Jun/2025
Inditex EUR 2.51B 7.98B Jan/2025
Merck EUR 1.46B 16M Sep/2025
Novartis USD 3.31B 134M Sep/2025
Philips EUR 1.18B 61M Sep/2025
Roche Holding CHF 7.28B 3.99B Dec/2025
Sanofi EUR 2.75B 455M Dec/2025
Smith & Nephew USD 1.42B 65M Dec/2025
UCB EUR 1.29B 221M Dec/2024
Viscofan EUR 72.59M 4.52M Mar/2025